Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | October 30, 2025 07:08am

Gainers

  • Intensity Therapeutics (NASDAQ:INTS) shares moved upwards by 183.2% to $0.76 during Thursday's pre-market session. The company's market cap stands at $13.0 million.
  • Tectonic Therapeutic (NASDAQ:TECX) shares rose 25.83% to $23.43. The company's market cap stands at $348.4 million.
  • Harvard Bioscience (NASDAQ:HBIO) stock moved upwards by 25.41% to $0.56. The market value of their outstanding shares is at $19.8 million.
  • VivoSim Labs (NASDAQ:VIVS) stock increased by 24.34% to $2.86. The company's market cap stands at $5.9 million.
  • Glaukos (NYSE:GKOS) stock increased by 20.93% to $93.23. The company's market cap stands at $4.4 billion. As per the news, the Q3 earnings report came out yesterday.
  • Guardant Health (NASDAQ:GH) shares rose 20.45% to $87.05. The market value of their outstanding shares is at $9.0 billion. The company's, Q3 earnings came out yesterday.

Losers

  • CERo Therapeutics Hldgs (NASDAQ:CERO) shares fell 76.1% to $0.43 during Thursday's pre-market session. The company's market cap stands at $3.3 million.
  • Purple Biotech (NASDAQ:PPBT) stock declined by 19.41% to $0.85. The market value of their outstanding shares is at $9.5 million.
  • Veru (NASDAQ:VERU) shares decreased by 18.58% to $2.85. The market value of their outstanding shares is at $51.2 million.
  • Processa Pharmaceuticals (NASDAQ:PCSA) stock decreased by 16.8% to $0.32. The market value of their outstanding shares is at $19.6 million.
  • Intellia Therapeutics (NASDAQ:NTLA) shares fell 15.63% to $11.07. The market value of their outstanding shares is at $1.4 billion.
  • VSee Health (NASDAQ:VSEE) shares fell 12.32% to $1.21. The market value of their outstanding shares is at $23.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: CERO GH GKOS HBIO INTS NTLA PCSA PPBT TECX VERU VIVS VSEE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist